Experts tie chemotherapy to slight increase in AML risk

02/14/2013 | HealthDay News

Patients who underwent chemotherapy for non-Hodgkin lymphoma and esophageal, prostate and cervical cancers faced an increased risk of developing acute myeloid leukemia, according to a new study. However, treatment was associated with lower AML risk in patients who had ovarian cancer, myeloma, and possibly lung cancer, researchers said. The findings appear in the journal Blood.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations